Summary

Asia CRO Market Research Report Forecast to 2032
Market Overview
Asia CRO Market is expected to register a significant CAGR of 12.87% during the review period. The increasing outsourcing of R&D and the growing complexity of drug development are boosting the demand for CRO services. Moreover, the rising prevalence of chronic diseases and government support for R&D are also fueling the growth of the market. However, a lack of experienced and skilled professionals to run tech-based equipment in CRO laboratories is hindering the growth of the Asia CRO market. Additionally, increasing number of clinical trials, growing demand for precision medicine, and the high incorporation of artificial intelligence (AI) and machine learning (ML) in CROs are creating lucrative opportunities for the market during the forecast period.
Contract research organization (CRO) is a company that provides research services to other companies on a contract basis. CROs are commonly used by pharmaceutical, biotechnology, and medical device companies to outsource certain aspects of their research and development (R&D) process. CROs can offer several benefits to sponsors, including access to a wide range of expertise in drug and device development, help sponsors reduce the cost of R&D by offering economies of scale, and provide sponsors with the flexibility to scale their R&D operations up or down as needed.
Market Segmentation
Based on the service type, the market has been segmented into pharmacovigilance, clinical research services, formulation, development service, laboratory services, consulting services, data management services, and interactive web response systems (IWRS) services.
On the basis of the application, the market has been segmented into vaccines, oncology, cardiovascular, respiratory, central nervous system, diabetes, autoimmune disorders, infectious diseases, and others.
On the basis of end user, Asia CRO market has been segmented into pharmaceutical and biopharmaceutical companies, medical device companies, academic institute, and others.
Regional Analysis
Asia-pacific contract research organization (CRO) market consists of Singapore, Malaysia, Thailand, Taiwan, South Korea, Philippines, Sri Lanka, Bangladesh, Vietnam and Rest of Asia-Pacific. The South Korea accounted for largest market share in 2022 and registered the highest CAGR during the forecast period.
In recent years, the Asia-Pacific region has become the hot spot for conducting clinical trials. As per Pharma Intelligence UK Limited (UK), the Asia-Pacific (APAC) region accounted for 50% of clinical trial activity globally in 2021. Moreover, in APAC, South Korea accounted for approximately 13% of the region in 2021.
Major Players
ClinActis (Singapore), OrciTrials (Singapore), Celero (Singapore), Expecto Health Science (Singapore), ACROSS Global Alliance Pte. Ltd. (Singapore), ClinActis Pte. Ltd. (Singapore), TMC Solutions Pte Ltd (Singapore), Experimental Drug Development Centre (Singapore), Info Kinetics Sdn Bhd (Penang, Malaysia), Clinical Research Malaysia (Kuala Lumpur, Malaysia), ACLIRES Bangkok Ltd. (Bangkok, Thailand), Asia Global Research Co., Ltd. (Bangkok, Thailand), Clinixir (Bangkok, Thailand), LSK Global Pharma Services Co., Ltd. (Seoul, South Korea), ADM Korea Inc. (Seoul, South Korea), Synex Consulting Ltd. (Seoul, South Korea), Seoul CRO (Seoul, South Korea), C&R RESEARCH Inc. (Seoul, South Korea),nMedi Helpline (Seoul, South Korea), Total Trial Management Consulting Co. Ltd. (Taipei, Taiwan), T-TOP Clinical Research Co., Ltd. (Taiwan), Efficient Pharma Management Corp. (EffPha) (Taiwan), Bangladesh Clinical Trials Limited (Dhaka, Bangladesh), Medica Innova Co,. Ltd. (Bangkok, Thailand), AMARC (Bangkok, Thailand), A2 Healthcare Taiwan Corp. (Taiwan), PROMEDIS (Seoul, South Korea), PiVOT (Pasig, Philippines), Pharmalytics Corporation (Cavite, Philippines), and RemediumOne (Colombo, Sri Lanka).

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
1.1 OVERVIEW 16
2 MARKET INTRODUCTION 18
2.1 DEFINITION 18
2.2 SCOPE OF THE STUDY 18
2.3 RESEARCH OBJECTIVESYSTEM 18
2.4 MARKET STRUCTURE 19
2.5 ASSUMPTIONS & LIMITATIONS 19
3 RESEARCH METHODOLOGY 20
3.1 DATA MINING 20
3.2 SECONDARY RESEARCH 21
3.3 PRIMARY RESEARCH 22
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 23
3.5 FORECASTING TECHNIQUES 23
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24
3.6.1 BOTTOM-UP APPROACH 25
3.6.2 TOP-DOWN APPROACH 25
3.7 DATA TRIANGULATION 26
3.8 VALIDATION 26
4 MARKET DYNAMICS 27
4.1 OVERVIEW 27
4.2 DRIVERS 28
4.2.1 RISING SPENDING ON R&D 28
4.2.2 GROWING NUMBER OF CLINICAL TRIALS OWING TO LARGE AND DIVERSE PATIENT POPULATIONS 28
4.2.3 COST-EFFECTIVE CRO SERVICES 29
4.3 RESTRAINTS 30
4.3.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS 30
4.4 OPPORTUNITY 31
4.4.1 GROWING DEMAND FOR INNOVATIVE HEALTHCARE SOLUTIONS 31
4.5 IMPACT OF COVID-19 ON CONTRACT RESEARCH ORGANIZATION MARKET 31
4.5.1 IMPACT ON COST 31
4.5.2 IMPACT ON SERVICES 32
4.5.3 IMPACT ON AVAILABILITY OF WORKFORCE 32
4.5.4 KEY STRATEGIES 32
4.6 ANALYSIS OF REGULATORY LANDSCAPE BY COUNTRY 34
5 ASIA CRO MARKET, BY SERVICE TYPE 41
5.1 OVERVIEW 41
5.2 CLINICAL RESEARCH SERVICES 47
5.3 FORMULATION DEVELOPMENT SERVICE 48
5.4 PHARMACOVIGILANCE SERVICES 49
5.5 LABORATORY SERVICES 50
5.6 CONSULTING SERVICES 51
5.7 BIOSTATISTICS SERVICES 52
5.8 MEDICAL WRITING SERVICES 53
5.9 DATA MANAGEMENT SERVICES 54
5.10 INTERACTIVE WEB RESPONSE SYSTEMS (IWRS) SERVICES 55
6 ASIA CRO MARKET, BY APPLICATION 56
6.1 OVERVIEW 56
6.2 VACCINES 61
6.3 ONCOLOGY 62
6.4 CARDIOVASCULAR 63
6.5 RESPIRATORY 64
6.6 CENTRAL NERVOUS SYSTEM 65
6.7 GASTROENTEROLOGY 66
6.8 DIABETES 67
6.9 AUTOIMMUNE DISORDERS 68
6.10 INFECTIOUS DISEASES 69
6.11 OTHERS 70
7 ASIA CRO MARKET, BY END USER 71
7.1 OVERVIEW 71
7.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 75
7.3 MEDICAL DEVICE COMPANIES 76
7.4 ACADEMIC INSTITUTES 77
7.5 OTHERS 78
8 ASIA CRO MARKET, BY COUNTRY 79
8.1 OVERVIEW 79
8.2 SOUTH KOREA 83
8.3 SINGAPORE 92
8.4 THAILAND 101
8.5 TAIWAN 110
8.6 MALAYSIA 119
8.7 PHILIPPINES 128
8.8 VIETNAM 137
8.9 BANGLADESH 146
8.10 SRI LANKA 155
9 COMPETITIVE LANDSCAPE 164
9.1 OVERVIEW 164
9.2 COMPETITIVE BENCHMARKING 165
9.3 MARKET SHARE ANALYSIS, 2022-2023 (%) 166
9.4 MAJOR PLAYERS SALES ANALYSIS 166
9.4.1 SALES 166
9.5 LIST OF EMERGING CROS IN KEY COUNTRIES 167
9.6 TOP 5 EMERGING CROS IN ASIA 168
9.6.1 LSK GLOBAL PHARMA SERVICES 168
9.6.2 EXPECTO HEALTH SCIENCE 168
9.6.3 MEDI HELP LINE CO., LTD. 168
9.6.4 C&R RESEARCH INC. 169
9.6.5 ADM KOREA INC 169
9.7 LIST OF DATA MANAGEMENT SOFTWARE USED BY CROS IN ASIA 170
9.8 TOTAL NUMBER OF CLINICAL TRIALS BY PHASE FOR MAJOR ASIA COUNTRIES (2019-2023) 171
9.9 BIBLIOGRAPHY 171
10 COMPANY PROFILES 173
10.1 SYNEOS HEALTH 173
10.1.1 COMPANY OVERVIEW 173
10.1.2 FINANCIAL OVERVIEW 173
10.1.3 SERVICES OFFERED 174
10.1.4 KEY DEVELOPMENTS 174
10.1.5 KEY STRATEGIES 174
10.2 PAREXEL INTERNATIONAL (MA) CORPORATION 175
10.2.1 COMPANY OVERVIEW 175
10.2.2 FINANCIAL OVERVIEW 175
10.2.3 SERVICES OFFERED 176
10.2.4 KEY DEVELOPMENTS 176
10.2.5 SWOT ANALYSIS 177
10.2.6 KEY STRATEGIES 177
10.3 MEDPACE 178
10.3.1 COMPANY OVERVIEW 178
10.3.2 FINANCIAL OVERVIEW 178
10.3.3 SERVICES OFFERED 178
10.3.4 KEY DEVELOPMENTS 180
10.3.5 KEY STRATEGIES 180
10.4 CMIC HOLDINGS CO., LTD 181
10.4.1 COMPANY OVERVIEW 181
10.4.2 FINANCIAL OVERVIEW 181
10.4.3 SERVICES OFFERED 182
10.4.4 KEY DEVELOPMENTS 183
10.4.5 KEY STRATEGIES 183
10.5 TIGERMED 184
10.5.1 COMPANY OVERVIEW 184
10.5.2 FINANCIAL OVERVIEW 184
10.5.3 SERVICES OFFERED 185
10.5.4 KEY DEVELOPMENTS 186
10.5.5 KEY STRATEGIES 186
10.6 IQVIA HOLDING, INC. 187
10.6.1 COMPANY OVERVIEWS 187
10.6.2 FINANCIAL OVERVIEW 187
10.6.3 SERVICES OFFERED 188
10.6.4 KEY DEVELOPMENTS 188
10.6.5 SWOT ANALYSIS 189
10.6.6 KEY STRATEGIES 189
10.7 ICON PLC 190
10.7.1 COMPANY OVERVIEW 190
10.7.2 FINANCIAL OVERVIEW 190
10.7.3 SERVICES OFFERED 191
10.7.4 KEY DEVELOPMENTS 192
10.7.5 SWOT ANALYSIS 193
10.7.6 KEY STRATEGIES 193
10.8 LABORATORY CORPORATION OF AMERICA HOLDINGS 194
10.8.1 COMPANY OVERVIEW 194
10.8.2 FINANCIAL OVERVIEW 194
10.8.3 SERVICES OFFERED 195
10.8.4 KEY DEVELOPMENTS 195
10.8.5 SWOT ANALYSIS 196
10.8.6 KEY STRATEGIES 196

10.9 PPD INC. 197
10.9.1 COMPANY OVERVIEW 197
10.9.2 FINANCIAL OVERVIEW 197
10.9.3 SERVICES OFFERED 198
10.9.4 KEY DEVELOPMENTS 198
10.9.5 SWOT ANALYSIS 199
10.9.6 KEY STRATEGIES 199
10.10 WUXI APPTEC 200
10.10.1 COMPANY OVERVIEW 200
10.10.2 FINANCIAL OVERVIEW 200
10.10.3 SERVICES OFFERED 201
10.10.4 KEY DEVELOPMENTS 201
10.10.5 KEY STRATEGIES 202
11 APPENDIX 203
11.1 REFERENCES 203
11.2 RELATED REPORTS 204

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22
TABLE 3 KEY STRATEGIES 32
TABLE 1 REGULATORY LANDSCAPE BY COUNTRY 34
TABLE 2 ASIA CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 46
TABLE 3 ASIA CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 47
TABLE 4 ASIA CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY COUNTRY, 2019–2032 (USD MILLION) 48
TABLE 5 ASIA CRO MARKET, FOR PHARMACOVIGILANCE SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 49
TABLE 6 ASIA CRO MARKET, FOR LABORATORY SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 50
TABLE 7 ASIA CRO MARKET, FOR CONSULTING SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 51
TABLE 8 ASIA CRO MARKET, FOR BIOSTATISTICS SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 52
TABLE 9 ASIA CRO MARKET, FOR MEDICAL WRITING SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 53
TABLE 10 ASIA CRO MARKET, FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 54
TABLE 11 ASIA CRO MARKET, FOR INTERACTIVE WEB RESPONSE SYSTEMS (IWRS) SERVICES, BY COUNTRY, 2019–2032 (USD MILLION) 55
TABLE 12 ASIA CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 60
TABLE 13 ASIA CRO MARKET, FOR VACCINES, BY COUNTRY, 2019–2032 (USD MILLION) 61
TABLE 14 ASIA CRO MARKET, FOR ONCOLOGY, BY COUNTRY, 2019–2032 (USD MILLION) 62
TABLE 15 ASIA CRO MARKET, FOR CARDIOVASCULAR, BY COUNTRY, 2019–2032 (USD MILLION) 63
TABLE 16 ASIA CRO MARKET, FOR RESPIRATORY, BY COUNTRY, 2019–2032 (USD MILLION) 64
TABLE 17 ASIA CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2019–2032 (USD MILLION) 65
TABLE 18 ASIA CRO MARKET, FOR GASTROENTEROLOGY, BY COUNTRY, 2019–2032 (USD MILLION) 66
TABLE 19 ASIA CRO MARKET, FOR DIABETES, BY COUNTRY, 2019–2032 (USD MILLION) 67
TABLE 20 ASIA CRO MARKET, FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2019–2032 (USD MILLION) 68
TABLE 21 ASIA CRO MARKET, FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2032 (USD MILLION) 69
TABLE 22 ASIA CRO MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 70
TABLE 23 ASIA CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 73
TABLE 24 ASIA CRO MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2032 (USD MILLION) 75
TABLE 25 ASIA CRO MARKET, FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2032 (USD MILLION) 76
TABLE 26 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019–2032 (USD MILLION) 77
TABLE 27 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019–2032 (USD MILLION) 78
TABLE 28 ASIA: CRO MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 82
TABLE 29 SOUTH KOREA: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 84
TABLE 30 SOUTH KOREA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 85
TABLE 31 SOUTH KOREA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 86
TABLE 32 SOUTH KOREA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 87
TABLE 33 SOUTH KOREA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 88
TABLE 34 SOUTH KOREA: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 89
TABLE 35 SOUTH KOREA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 36 SOUTH KOREA: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 91
TABLE 37 SINGAPORE: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 93
TABLE 38 SINGAPORE: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 94
TABLE 39 SINGAPORE: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 95
TABLE 40 SINGAPORE: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 96
TABLE 41 SINGAPORE: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 97
TABLE 42 SINGAPORE: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 98
TABLE 43 SINGAPORE: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 99
TABLE 44 SINGAPORE: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 100
TABLE 45 THAILAND: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 102
TABLE 46 THAILAND: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 103
TABLE 47 THAILAND: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 104
TABLE 48 THAILAND: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 105
TABLE 49 THAILAND: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 106
TABLE 50 THAILAND: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 107
TABLE 51 THAILAND: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 108
TABLE 52 THAILAND: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 109
TABLE 53 TAIWAN: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 111
TABLE 54 TAIWAN: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 112
TABLE 55 TAIWAN: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 113
TABLE 56 TAIWAN: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 114
TABLE 57 TAIWAN: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 115
TABLE 58 TAIWAN: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 116
TABLE 59 TAIWAN: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 117
TABLE 60 TAIWAN: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 118
TABLE 61 MALAYSIA: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 120
TABLE 62 MALAYSIA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 121
TABLE 63 MALAYSIA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 122
TABLE 64 MALAYSIA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 123
TABLE 65 MALAYSIA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 124
TABLE 66 MALAYSIA: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 125
TABLE 67 MALAYSIA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 126
TABLE 68 MALAYSIA: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 127
TABLE 69 PHILIPPINES: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 129
TABLE 70 PHILIPPINES: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 130
TABLE 71 PHILIPPINES: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 131
TABLE 72 PHILIPPINES: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 132
TABLE 73 PHILIPPINES: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 133
TABLE 74 PHILIPPINES: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 134
TABLE 75 PHILIPPINES: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 135
TABLE 76 PHILIPPINES: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 136
TABLE 77 VIETNAM: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 138
TABLE 78 VIETNAM: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 139
TABLE 79 VIETNAM: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 140
TABLE 80 VIETNAM: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 141
TABLE 81 VIETNAM: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 142
TABLE 82 VIETNAM: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 143
TABLE 83 VIETNAM: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 144
TABLE 84 VIETNAM: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 145
TABLE 85 BANGLADESH: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 147
TABLE 86 BANGLADESH: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 148
TABLE 87 BANGLADESH: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 149
TABLE 88 BANGLADESH: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 150
TABLE 89 BANGLADESH: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 151
TABLE 90 BANGLADESH: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 152
TABLE 91 BANGLADESH: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 153
TABLE 92 BANGLADESH: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 154
TABLE 93 SRI LANKA: CRO MARKET, BY SERVICE TYPE, 2019–2032 (USD MILLION) 156
TABLE 94 SRI LANKA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019–2032 (USD MILLION) 157
TABLE 95 SRI LANKA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019–2032 (USD MILLION) 158
TABLE 96 SRI LANKA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2032 (USD MILLION) 159
TABLE 97 SRI LANKA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019–2032 (USD MILLION) 160
TABLE 98 SRI LANKA: CRO MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 161
TABLE 99 SRI LANKA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019–2032 (USD MILLION) 162
TABLE 100 SRI LANKA: CRO MARKET, BY END USER, 2019–2032 (USD MILLION) 163
TABLE 101 MAJOR PLAYERS IN THE ASIA CRO MARKET 164
TABLE 102 LIST OF EMERGING CROS IN KEY COUNTRIES 167
TABLE 103 LIST OF DATA MANAGEMENT SOFTWARE USED BY CROS IN ASIA 170
TABLE 104 TOTAL NUMBER OF CLINICAL TRIALS BY PHASE FOR MAJOR ASIA COUNTRIES (2019-2023) 171
TABLE 105 BIBLIOGRAPHY 171
TABLE 106 SYNEOS HEALTH: SERVICE OFFERED 174
TABLE 107 PAREXEL INTERNATIONAL (MA) CORPORATION: SERVICE OFFERED 176
TABLE 108 MEDPACE: SERVICES OFFERED 178
TABLE 109 CMIC HOLDINGS CO., LTD: SERVICES OFFERED 182
TABLE 110 TIGERMED : SERVICES OFFERED 185
TABLE 111 IQVIA HOLDING, INC.: SERVICES OFFERED 188
TABLE 112 ICON PLC: SERVICES OFFERED 191
TABLE 113 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 195
TABLE 114 PPD INC.: SERVICES OFFERED 198
TABLE 115 WUXI APPTEC: SERVICES OFFERED 201